Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1864046Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$1.6M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#7,481
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing David E Fisher as a PI. Multi-PI records show the full award amount for context.
- 2P01CA163222-11P01Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment$537.6Kaward amount
- $519.2Kaward amount
- 5R01AR072304-07R01Therapeutic strategies for treatment of giant congenital melanocytic nevi$496.3Kaward amount
- 3R01AR072304-07S1R01Therapeutic strategies for treatment of giant congenital melanocytic nevi$96.5Kaward amount
Award organization
Organizations that administered FY2024 awards listing David E Fisher as a PI.
FY2024 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7481
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as David E Fisher.